![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/22/2916520/0/en/HOOKIPA-Pharma-Announces-Leadership-Changes-to-Intensify-Focus-on-HB-200.html
https://www.globenewswire.com/news-release/2024/07/08/2909514/0/en/HOOKIPA-Pharma-Announces-Effective-Date-of-1-for-10-Reverse-Stock-Split.html
https://www.globenewswire.com/news-release/2024/07/01/2907081/0/en/HOOKIPA-Pharma-Announces-First-Person-Dosed-in-Phase-1b-Clinical-Trial-of-HB-500-for-the-Treatment-of-HIV.html
https://www.globenewswire.com/news-release/2024/06/04/2893345/0/en/HOOKIPA-Pharma-Announces-Updated-Phase-2-Clinical-Data-at-the-American-Society-of-Clinical-Oncology-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/30/2891156/0/en/HOOKIPA-Pharma-to-Host-Investor-Call-on-HB-200-Data-Presented-at-American-Society-of-Clinical-Oncology-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/23/2887693/0/en/HOOKIPA-Pharma-Announces-Positive-Clinical-Data-to-be-Presented-at-the-American-Society-for-Clinical-Oncology-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/09/2878623/0/en/HOOKIPA-Pharma-Reports-First-Quarter-2024-Financial-Results-and-Recent-Business-Highlights.html
https://www.globenewswire.com/news-release/2024/04/25/2869506/0/en/HOOKIPA-Pharma-Announces-Pivotal-Phase-2-3-Trial-Design-for-HB-200-in-Combination-with-Pembrolizumab.html
https://www.globenewswire.com/news-release/2024/04/24/2868480/0/en/HOOKIPA-Pharma-Announces-FDA-Clearance-of-its-Investigational-New-Drug-Application-for-HB-700-for-the-Treatment-of-KRAS-Mutated-Cancers.html
https://www.globenewswire.com/news-release/2024/04/16/2864116/0/en/HOOKIPA-Pharma-Announces-Grant-of-Inducement-Award-Under-Nasdaq-Listing-Rule-5635-c-4.html